Stabilisation and Knockdown of HIF - Two Distinct Ways Comparably Important in Radiotherapy

Background: Radiotherapy is one of the most widely used treatments for cancer. The benefit of radiation is known to be negatively affected by tumor hypoxia and the expression of hypoxia-inducible factors (HIF), respectively. HIF-1 alpha/beta and HIF-2 alpha/beta are transcriptional activators of oxygen-regulated genes. The aim of the study was to examine cell type-specific effects of HIF-1 alpha and -2 alpha knockdown or oxygen-independent HIF-stabilisation on radiosensitivity. Methods: Herein, we treated four different wildtype and HIF-1 alpha- or HIF-2 alpha-deficient human cancer cell lines, cultured under normoxic or hypoxic conditions, with ionising radiation in doses from 2 to 6 Gy and examined clonogenic survival. Furthermore, the cells were partly preincubated with a HIF-stabiliser (di-tert-butyroyl-oxymethyl-2,4-pyridine-dicarboxylate, (t)Bu-2,4-PDC). Results: The results show that both hypoxia exposure and treatment with (t)Bu-2,4-PDC increased the radioresistance of human cancer cells. The HIF-mediated decrease of radioresponsiveness induced by the chemical stabiliser emerged to be as strong as the one caused by hypoxia. Clonogenic survival assays furthermore revealed that HIF-1 expression enhanced resistance to radiation, whereas knocking-down HIF-1 increased the sensitivity to radiation under normoxic as well as under hypoxic conditions. Conclusion: These data extend previous observations of HIF-1 alpha and broaden the view by showing HIF-2 alpha inverse correlation between HIF expression and prognosis for the outcome of radiotherapy. Copyright (C) 2011 S. Karger AG, Basel